As much as I don't want you to be right, I think you are. I feel that Novartis would have finalised this deal months ago if they were pleased with it. I feel like big pharma will let go of the reigns now on MSB and enter at a much lower price. Perhaps even buy them out once they squeeze the price back into the $1 region. Happy to hear the contrary, I don't mind either way for now as I'm a big believer in the cells, just don't think it should be 5+ years away
Cell Therapy News/Articles, page-9751
-
- There are more pages in this discussion • 8,678 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 44452 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 23596 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |